Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence

Acta Obstetricia et Gynecologica Scandinavica

Volumn 93, Issue 1, 2014, Pages 38-44

  Cho, Sihyun ^a,d   Jung, Ji Ann ^b   Lee, Yousun ^a   Kim, Hye Yeon ^c,d   Seo, Seok Kyo ^b,d   Choi, Young Sik ^b,d   Lee, Ji Sung ^e   Lee, Byung Seok ^a,d  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Gachon University   (South Korea)

Author keywords

CA 125; endometrioma; Levonorgestrel releasing intrauterine system; oral contraceptive; recurrence

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT;

ADULT; CONTRACEPTIVES, ORAL, HORMONAL; DISEASE-FREE SURVIVAL; ENDOMETRIOSIS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEUPROLIDE; LEVONORGESTREL; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84890476801     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12294     Document Type: Article

References (38)

1. Fauconnier A, Chapron C,. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005; 11: 595-606.
2. Fauconnier A, Fritel X, Chapron C,. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Gynecol Obstet Fertil. 2009; 37: 57-69.
3. Seracchioli R, Mabrouk M, Manuzzi L, Vicenzi C, Frasca C, Elmakky A, et al. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod. 2009; 24: 2729-35.
4. Jain S, Dalton ME,. Chocolate cysts from ovarian follicles. Fertil Steril. 1999; 72: 852-6.
5. Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB,. Management of ovarian endometriomas. Hum Reprod Update. 2002; 8: 591-7.
6. Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW,. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol. 2007; 109: 1411-20.
7. Vercellini P, Somigliana E, Vigano P, Abbiati A, Barbara G, Fedele L,. 'Blood On The Tracks' from corpora lutea to endometriomas. BJOG. 2009; 116: 366-71.
8. Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R,. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004; 82: 878-84.
9. Busacca M, Bianchi S, Agnoli B, Candiani M, Calia C, De Marinis S, et al. Follow-up of laparoscopic treatment of stage III-IV endometriosis. J Am Assoc Gynecol Laparosc. 1999; 6: 55-8.
10. Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG,. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008; 198: e1-5.
11. Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P,. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol. 2012; 119: 519-26.
12. Takamura M, Koga K, Osuga Y, Takemura Y, Hamasaki K, Hirota Y, et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod. 2009; 24: 3042-8.
13. Bayoglu Tekin Y, Dilbaz B, Altinbas SK, Dilbaz S,. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril. 2011; 95: 492-6.
14. Witt BR, Barad DH,. Management of endometriosis in women older than 40 years of age. Obstet Gynecol Clin North Am. 1993; 20: 349-63.
15. Busacca M,. Pain and endometriosis: an overview. J Minim Invasive Gynecol. 2006; 13: 573-5.
16. Vercellini P, Frontino G, De Giorgi O, Aimi G, Zaina B, Crosignani PG,. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003; 80: 305-9.
17. The American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67: 817-21.
18. Exacoustos C, Zupi E, Carusotti C, Rinaldo D, Marconi D, Lanzi G, et al. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc. 2003; 10: 378-82.
19. Fraser IS,. Non-contraceptive health benefits of intrauterine hormonal systems. Contraception. 2010; 82: 396-403.
20. Vercellini P, Aimi P, Panazza S, De Giorgi O, Pesole A, Crosignani PG,. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril. 1999; 72: 505-8.
21. Fedele L, Bianchi S, Zanconato G, Portuese A, Raffaelli R,. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril. 2001; 75: 485-8.
22. Gomes MK, Rosa-e-Silva JC, Garcia SB, de Sa Rosa-e-Silva AC, Turatti A, Vieira CS, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod. 2009; 24: 2736-45.
23. Engemise SL, Willets JM, Taylor AH, Emembolu JO, Konje JC,. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system. Eur J Obstet Gynecol Reprod Biol. 2011; 157: 101-6.
24. Lockhat FB, Emembolu JE, Konje JC,. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertil Steril. 2005a; 83: 398-404.
25. Vercellini P, Vigano P, Somigliana E,. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis. Curr Opin Obstet Gynecol. 2005; 17: 359-65.
26. Sesti F, Capozzolo T, Pietropolli A, Marziali M, Bollea MR, Piccione E,. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Eur J Obstet Gynecol Reprod Biol. 2009; 147: 72-7.
27. Lee DY, Bae DS, Yoon BK, Choi D,. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod. 2010; 25: 3050-4.
28. Seracchioli R, Mabrouk M, Frasca C, Manuzzi L, Savelli L, Venturoli S,. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010a; 94: 464-71.
29. Lockhat FB, Emembolu JO, Konje JC,. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod. 2005b; 20: 789-93.
30. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa e Silva JC, Podgaec S, et al. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system. Eur J Obstet Gynecol Reprod Biol. 2009; 143: 128-9.
31. Seracchioli R, Mabrouk M, Frasca C, Manuzzi L, Montanari G, Keramyda A, et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril. 2010b; 93: 52-6.
32. Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Labate F, et al. The role of endovaginal ultrasound in differentiating endometriomas from other ovarian cysts. Clin Exp Obstet Gynecol. 1995; 22: 20-2.
33. Sokalska A, Timmerman D, Testa AC, Van Holsbeke C, Lissoni AA, Leone FP, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol. 2009; 34: 462-70.
34. Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB,. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril. 1993; 60: 776-80.
35. Van Holsbeke C, Van Calster B, Guerriero S, Savelli L, Paladini D, Lissoni AA, et al. Endometriomas: their ultrasound characteristics. Ultrasound Obstet Gynecol. 2010; 35: 730-40.
36. Guo SW,. Recurrence of endometriosis and its control. Hum Reprod Update. 2009; 15: 441-61.
37. Mirena Highlights of prescribing information. Available online at: http://labeling.bayerhealthcare.com/html/products/pi/Mirena-PI.pdf.
38. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I,. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception. 2011; 84: e11-6.